Cargando…
A Single‐Center Experience on Outcomes of Complementary and Alternative Medicine Use Among Patients With Cirrhosis
Drug‐induced liver injury (DILI) due to complementary and alternative medicine (CAM) use is on the rise throughout the world by patients looking for “safer” alternatives. However, data on acute‐on‐chronic liver failure (ACLF) due to CAM are lacking. In a large cohort of patients with cirrhosis, we r...
Autores principales: | Philips, Cyriac Abby, Paramaguru, Rajaguru, Augustine, Philip, Rajesh, Sasidharan, Ahamed, Rizwan, George, Tom, Padsalgi, Guruprasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601323/ https://www.ncbi.nlm.nih.gov/pubmed/31304453 http://dx.doi.org/10.1002/hep4.1355 |
Ejemplares similares
-
Repurposing Pirfenidone for Nonalcoholic Steatohepatitis-related Cirrhosis: A Case Series
por: Philips, Cyriac Abby, et al.
Publicado: (2020) -
Ayurveda Herbal Medicine-induced Liver Cirrhosis
por: Philips, Cyriac A, et al.
Publicado: (2019) -
Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options
por: Philips, Cyriac Abby, et al.
Publicado: (2019) -
Clinical outcomes associated with complementary and alternative medicine-related “immunity-boosting” practices in patients with cirrhosis during the COVID-19 pandemic – an observational study
por: Philips, Cyriac Abby, et al.
Publicado: (2023) -
Update on diagnosis and management of sepsis in cirrhosis: Current advances
por: Philips, Cyriac Abby, et al.
Publicado: (2020)